Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 372 of 5804
-
Can a single dose predict autism treatment success?
Symptom relief Recruiting nowstudy with arbaclofen (4 weeks of titration and then 6 weeks of active/stable treatment). The effects of arbaclofen on target EEG and ERG metrics will be associated with the clinical response in measures of social and general function, adaptive behaviour, social anxiety, sensory …
Phase: PHASE3 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New hope for Alzheimer's? phase 3 trial of DMB-I begins
Disease control Recruiting nowThe goal of this clinical study is to learn if the study drug DMB-I (INN: Latrepirdine) works to treat Alzheimer type dementia in adults. It will also learn about the safety of DMB-I (INN: Latrepirdine). The main questions it aims to answer are: * Does DMB-I improve cognitive f…
Phase: PHASE3 • Sponsor: Bigespas LTD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could less radiation be better for some head and neck cancers?
Disease control Recruiting nowThis study aims to explore the efficacy and adverse events of reduced-dose radiotherapy (40.2Gy) versus conventional-dose radiotherapy (49.2Gy) to low-risk target volume for chemosensitive intermediate-stage nasopharyngeal carcinoma patients.
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail aims to beat tough lymphoma
Disease control Recruiting nowDiffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Currently, the first-line treatment regimen based on R-CHOP can only achieve clinical cure for 50% to 60% of patients. Previous studies have shown that patients with high-risk factors have a …
Phase: PHASE2 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to stop youth mental health crises before they start
Prevention Recruiting nowThis randomized controlled trial aims to evaluate the effectiveness of participation in five different STIME (Strengthened Cross-Sectoral Initiative for Children and Young People's Mental Health) interventions: 'Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Sel…
Phase: NA • Sponsor: Center for Clinical Research and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New novavax JN.1 vaccine trial aims to protect adults 50-64 from COVID
⭐️ VACCINE ⭐️ OngoingThis is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine. Approximately 6,500 healthy adults aged 50 to under 65 will be randomized to receive either the vaccine or a placebo, with follow-up for …
Phase: PHASE4 • Sponsor: Novavax • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:30 UTC
-
New method aims to help premature babies breathe easier without a breathing tube
Disease control ENROLLING_BY_INVITATIONThe purpose of this research is to learn new information that may help other infants that have respiratory distress syndrome and need breathing support after birth. The goal of this research is to see if continuous positive airway pressure (CPAP) alone or CPAP with surfactant adm…
Phase: NA • Sponsor: Sharp HealthCare • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Simple blood or saliva test may predict postpartum depression in pregnancy
Diagnosis Recruiting nowThe study will seek to prospectively validate the Enlighten Device for prediction of PPD by examining true/false positive and negative rates of the test using PPD outcomes collected through 3 months postpartum; compare the accuracy of biomarkers and algorithm in determining risk …
Sponsor: University of Virginia • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New hope for advanced cervical cancer: experimental drug SYS6002 faces chemo in major trial
Disease control Not yet recruitingThis study is a randomized, open-label, controlled, multicenter phase Ⅲ clinical trial, which aims to evaluate the efficacy and safety of SYS6002 versus investigator's choice of chemotherapy in the treatment of participants with recurrent or metastatic cervical cancer who have fa…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Sound waves target kidney fat to lower stubborn blood pressure
Disease control Not yet recruitingThe goal of this clinical trial is to investigate if focused power ultrasound (FPU) targeted perirenal adipose tissue modification therapy would be effective and safe in treating resistant hypertension. The primary outcome of the study is the difference in the reduction of 24h me…
Phase: PHASE3 • Sponsor: Yan Li • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could delaying radiation be just as good for advanced nasopharyngeal cancer?
Disease control Recruiting nowThis phase III randomized trial evaluates PD-1 inhibitor plus chemotherapy followed by immediate versus salvage locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma. The study aims to evaluate whether salvage locoregional radiotherapy is non-inferior to immedi…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New shot before angioplasty may shield heart attack patients
Disease control Not yet recruitingThe goal of this clinical trial is to learn if drug tafolecimab works to treat participants with acute myocardial infarction (AMI) scheduled for primary percutaneous coronary intervention (PCI). It will also learn about the safety of drug tafolecimab. The main questions it aims t…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug cocktail targets Hard-to-Treat bladder cancer
Disease control Recruiting nowThis is a multicenter, open-label, Phase II clinical trial to evaluate the efficacy and safety of Trastuzumab Rezetecan (SHR-A1811) or in combination with Adebrelimab (SHR-1316) for HER2-expressing locally advanced or metastatic urothelial carcinoma (la/mUC).
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to shrink tough stomach cancers
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the addition of ivonescimab to standard chemotherapy in patients with advanced or metastatic gastric and gastroesophageal adenocarcinoma. The main question it aims to answer is : Does the addition of ivonescimab increase the response…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill targets genetic form of polycystic kidney disease
Disease control Recruiting nowThe purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharmacokinetics (PK) of VX-407.
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain implant that learns: new hope for Parkinson's?
Disease control Recruiting nowThe purpose of the study is to evaluate the effectiveness of the Medtronic Adaptive DBS therapy (aDBS) for Parkinson's Disease in China with the Percept family of Implantable Neurostimulators (Percept PC and Percept RC).
Phase: NA • Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug trial aims to help kids with heart failure
Disease control Recruiting nowResearchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where the heart is unable to pump enough blood to meet the body's needs. This can lead to symptoms like shortn…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pacemaker strategy could cut heart failure deaths after valve surgery
Disease control Recruiting nowIn this prospective, randomized, multicenter, open-label interventional clinical trial, the investigators' aim to test the effect of Cardiac Resynchronization Therapy (CRT) in cases of new-onset and persistent Left Bundle Branch Block (LBBB) occurring in the context of Transcathe…
Phase: NA • Sponsor: Semmelweis University Heart and Vascular Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New Camera-Guided surgery may cut recurrence of brain blood clots
Disease control Recruiting nowChronic subdural hematoma (CSDH) is a frequent condition in neurosurgery, leading to fluid accumulation between the meninges, brain compression, neurological dysfunction, and potentially herniation. The efficacy of treatments and their long-term outcomes remain uncertain, with no…
Phase: NA • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Frozen testicle tissue may help cancer survivors become dads
Disease control Recruiting nowThis is a pilot clinical trial to evaluate the feasibility and outcome of autologous transplantation of immature testicular tissue cryopreserved during childhood as a method of fertility preservation for prepubertal boys in case of gonadotoxic therapies. Freezing of immature tes…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC